Lannett $1.23 billion acquisition of Kremers Urban Pharmaceuticals

Overview:

• Lannett has completed its $1.23 billion acquisition of Kremers Urban Pharmaceuticals.
• Kremers Urban was sold by Brussels-based multinational pharmaceutical company UCB.
• Lannett financed the deal via a $1.29 billion notes issue and $1.04 billion credit facility.
• The deal was first announced in September, 2015.
• Debevoise & Plimpton (Andrew Bab, Jennifer Chu, Scott Selinger) and Fox Rothschild (Bradley Rodos, Stephen Brill, David Jaffe) advised Lannett.
• Covington & Burling (JD Weinberg, Kyle Rabe) advised UCB.

Kurt Stumpo - Journalist - North America and the Caribbean